CL2014000509A1 - Co-cristales que comprenden ciprodinil y ditianon; proceso para preparar los co-cristales; composicion para la proteccion de cultivos que comprende dichos co-cristales; uso para combatir hobgos fitopatógenos. - Google Patents

Co-cristales que comprenden ciprodinil y ditianon; proceso para preparar los co-cristales; composicion para la proteccion de cultivos que comprende dichos co-cristales; uso para combatir hobgos fitopatógenos.

Info

Publication number
CL2014000509A1
CL2014000509A1 CL2014000509A CL2014000509A CL2014000509A1 CL 2014000509 A1 CL2014000509 A1 CL 2014000509A1 CL 2014000509 A CL2014000509 A CL 2014000509A CL 2014000509 A CL2014000509 A CL 2014000509A CL 2014000509 A1 CL2014000509 A1 CL 2014000509A1
Authority
CL
Chile
Prior art keywords
crystals
hobgos
ciprodinyl
dithianon
prepare
Prior art date
Application number
CL2014000509A
Other languages
English (en)
Inventor
Randall Evan Gold
Christian Sowa
Tiziana Chiodo
Ralf Vogel
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47755412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014000509(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Se filed Critical Basf Se
Publication of CL2014000509A1 publication Critical patent/CL2014000509A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/32Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CL2014000509A 2011-08-30 2014-02-28 Co-cristales que comprenden ciprodinil y ditianon; proceso para preparar los co-cristales; composicion para la proteccion de cultivos que comprende dichos co-cristales; uso para combatir hobgos fitopatógenos. CL2014000509A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161528776P 2011-08-30 2011-08-30
EP11179335 2011-08-30
EP12159171 2012-03-13

Publications (1)

Publication Number Publication Date
CL2014000509A1 true CL2014000509A1 (es) 2014-10-17

Family

ID=47755412

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000509A CL2014000509A1 (es) 2011-08-30 2014-02-28 Co-cristales que comprenden ciprodinil y ditianon; proceso para preparar los co-cristales; composicion para la proteccion de cultivos que comprende dichos co-cristales; uso para combatir hobgos fitopatógenos.

Country Status (16)

Country Link
US (1) US20140205641A1 (es)
EP (1) EP2751085B1 (es)
KR (1) KR20140054364A (es)
CN (1) CN103764632B (es)
AU (1) AU2012303649A1 (es)
BR (1) BR112014004283A2 (es)
CA (1) CA2844014A1 (es)
CL (1) CL2014000509A1 (es)
CO (1) CO6920299A2 (es)
CR (1) CR20140083A (es)
EA (1) EA025318B1 (es)
IL (1) IL230738A0 (es)
MX (1) MX2014002068A (es)
PE (1) PE20141533A1 (es)
PL (1) PL2751085T3 (es)
WO (1) WO2013030777A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2877030A1 (en) 2012-06-22 2013-12-27 Basf Se Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
US9567317B2 (en) 2012-10-19 2017-02-14 Basf Se Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
MX2016001096A (es) 2013-07-25 2016-04-25 Basf Se Sales de dasatinib en forma amorfa.
JP6501773B2 (ja) 2013-07-25 2019-04-17 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se 結晶形態のダサチニブの塩
US9850181B1 (en) 2015-08-06 2017-12-26 The United States Of America As Represented By The Secretary Of The Army Single-step production method for nano-sized energetic cocrystals by bead milling and products thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1521526B3 (de) * 2002-07-08 2012-08-15 Basf Se Fungizide mischungen auf basis von dithianon
DE602006021644D1 (de) * 2005-09-29 2011-06-09 Syngenta Participations Ag Fungizidzusammensetzungen
GB0706044D0 (en) * 2007-03-28 2007-05-09 Syngenta Ltd C0-Crystals
CA2696685A1 (en) * 2007-09-07 2009-04-16 Basf Se Co-crystals of pyrimethanil and dithianon
GB0812028D0 (en) * 2008-07-01 2008-08-06 Syngenta Participations Ag Fungicidal compositions
GB0817976D0 (en) * 2008-10-01 2008-11-05 Syngenta Ltd Co-crystals

Also Published As

Publication number Publication date
EP2751085A1 (en) 2014-07-09
CA2844014A1 (en) 2013-03-07
EA025318B1 (ru) 2016-12-30
CR20140083A (es) 2014-05-08
EA201400282A1 (ru) 2014-07-30
WO2013030777A1 (en) 2013-03-07
CN103764632B (zh) 2017-05-17
AU2012303649A1 (en) 2014-03-20
PL2751085T3 (pl) 2017-05-31
CN103764632A (zh) 2014-04-30
MX2014002068A (es) 2014-05-30
EP2751085B1 (en) 2016-11-23
IL230738A0 (en) 2014-03-31
KR20140054364A (ko) 2014-05-08
CO6920299A2 (es) 2014-04-10
PE20141533A1 (es) 2014-11-14
EP2751085A4 (en) 2015-04-29
US20140205641A1 (en) 2014-07-24
BR112014004283A2 (pt) 2017-03-21

Similar Documents

Publication Publication Date Title
CL2014003357A1 (es) Composición sinérgica para la protección de cultivos agrícolas y su uso
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
CR20140259A (es) Compuestos novedosos de benzopirano, composiciones y usos de los mismos
CL2014003136A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
BR112013023681A2 (pt) compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
BR112015002767A2 (pt) composições, métodos, e sistemas para a síntese e uso de agentes de imagiologia
BR112013023174A2 (pt) "compostos derivados de triterpenoide de c4-monometila, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos"
CL2014001047A1 (es) Compuestos heterociclicos derivados de pirazina; composicion y combinacion farmaceutica que los contienen y el uso en enfermedades respiratorias y alergicas.
CL2014003191A1 (es) Compuestos que inhiben la actividad de catecol o -metiltransferasa; su uso contra el parkinson.
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
CL2014000447A1 (es) Compuestos derivados de piridina y pirimidina sustituidos, mediadores de quinurenina-3-monooxigenasa; composiciones farmaceuticas que los comprenden; y uso en el tratamiento de una patologia neurodegenerativa, tal como la enfermedad de huntington.
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
CO6950497A2 (es) Compuestos de 1,2,5-oxadiazol sustituidos y su uso como herbicidas
CL2013001604A1 (es) Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis.
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
CR20140263A (es) Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(-4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo
CL2013000734A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para bajar la presion intraocular; kit farmaceutico.
CL2014002986A1 (es) Proceso para la preparacion de compuestos derivados de 2-(1-hidroxi-alquil)-cromen-4-ona opticamente puros y opcionalmente sustituidos; compuestos derivados de 2-(1-hidroxi-alquil)-cromen-4-ona; composicion farmaceutica que los comprende; y su uso para preparar compuestos inhibidores de pi3k.
CL2014000509A1 (es) Co-cristales que comprenden ciprodinil y ditianon; proceso para preparar los co-cristales; composicion para la proteccion de cultivos que comprende dichos co-cristales; uso para combatir hobgos fitopatógenos.
CL2014001862A1 (es) Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.
CL2014002951A1 (es) (r)-nifuratel; formulacion farmaceutica que lo contiene; y proceso para fabricar (r)-nifuratel y (s)-nifuratel.